These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19583732)

  • 1. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.
    Lowrance WT; Thompson RH; Yee DS; Kaag M; Donat SM; Russo P
    BJU Int; 2010 Jan; 105(1):16-20. PubMed ID: 19583732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
    Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
    Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis.
    Callahan CL; Hofmann JN; Corley DA; Zhao WK; Shuch B; Chow WH; Purdue MP
    Cancer Epidemiol; 2018 Oct; 56():31-37. PubMed ID: 30029068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early life body size in relation to risk of renal cell carcinoma in adulthood: a Danish observational cohort study.
    Jensen BW; Meyle KD; Madsen K; Sørensen TIA; Baker JL
    Eur J Epidemiol; 2020 Mar; 35(3):251-258. PubMed ID: 31993884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.
    Hakimi AA; Furberg H; Zabor EC; Jacobsen A; Schultz N; Ciriello G; Mikklineni N; Fiegoli B; Kim PH; Voss MH; Shen H; Laird PW; Sander C; Reuter VE; Motzer RJ; Hsieh JJ; Russo P
    J Natl Cancer Inst; 2013 Dec; 105(24):1862-70. PubMed ID: 24285872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours.
    Karlo CA; Kou L; Di Paolo PL; Kattan MW; Motzer RJ; Russo P; Tickoo SK; Akin O; Hricak H
    Eur J Cancer; 2016 May; 59():57-64. PubMed ID: 27016623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.
    Purdue MP; Moore LE; Merino MJ; Boffetta P; Colt JS; Schwartz KL; Bencko V; Davis FG; Graubard BI; Janout V; Ruterbusch JJ; Beebe-Dimmer J; Cote ML; Shuch B; Mates D; Hofmann JN; Foretova L; Rothman N; Szeszenia-Dabrowska N; Matveev V; Wacholder S; Zaridze D; Linehan WM; Brennan P; Chow WH
    Int J Cancer; 2013 Jun; 132(11):2640-7. PubMed ID: 23150424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma: A Large Cohort Analysis.
    Lee WK; Hong SK; Lee S; Kwak C; Oh JJ; Jeong CW; Kim YJ; Kang SH; Hong SH; Byun SS
    Clin Genitourin Cancer; 2015 Oct; 13(5):461-8. PubMed ID: 25990340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China.
    Wang HK; Song XS; Cheng Y; Qu YY; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu YP; Shi GH; Qin XJ; Ma CG; Lin GW; Xiao WJ; Zhu Y; Ye DW
    BJU Int; 2014 Oct; 114(4):496-502. PubMed ID: 25383400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study.
    Lindblad P; Wolk A; Bergström R; Persson I; Adami HO
    Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):631-9. PubMed ID: 7881335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and renal cell carcinoma: Biological mechanisms and perspectives.
    Venkatesh N; Martini A; McQuade JL; Msaouel P; Hahn AW
    Semin Cancer Biol; 2023 Sep; 94():21-33. PubMed ID: 37286114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
    Parker AS; Lohse CM; Cheville JC; Thiel DD; Leibovich BC; Blute ML
    Urology; 2006 Oct; 68(4):741-6. PubMed ID: 17070345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifetime Body Weight Trajectories and Risk of Renal Cell Cancer: A Large U.S. Prospective Cohort Study.
    Deng Z; Hajihosseini M; Moore JX; Khan S; Graff RE; Bondy ML; Chung BI; Langston ME
    Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1651-1659. PubMed ID: 37624040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer.
    Blute ML; Zorn K; Grimes M; Shi F; Downs TM; Jarrard DF; Best SL; Richards K; Nakada SY; Abel EJ
    BJU Int; 2016 Sep; 118(3):399-407. PubMed ID: 26589741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC.
    Turco F; Tucci M; Di Stefano RF; Samuelly A; Bungaro M; Audisio M; Pisano C; Di Maio M; Scagliotti GV; Buttigliero C
    Endocr Relat Cancer; 2021 Jun; 28(7):R207-R216. PubMed ID: 33949971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and the clinicopathological characteristics of clinically localized renal masses-An international retrospective review.
    Tsivian E; Tsivian M; Tay KJ; Longo T; Zukerman Z; Martorana G; Schiavina R; Brunocilla E; Polascik TJ
    Urol Oncol; 2017 Jul; 35(7):459.e1-459.e5. PubMed ID: 28284892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Pischon T; Lahmann PH; Boeing H; Tjønneland A; Halkjaer J; Overvad K; Klipstein-Grobusch K; Linseisen J; Becker N; Trichopoulou A; Benetou V; Trichopoulos D; Sieri S; Palli D; Tumino R; Vineis P; Panico S; Monninkhof E; Peeters PH; Bueno-de-Mesquita HB; Büchner FL; Ljungberg B; Hallmans G; Berglund G; Gonzalez CA; Dorronsoro M; Gurrea AB; Navarro C; Martinez C; Quirós JR; Roddam A; Allen N; Bingham S; Khaw KT; Kaaks R; Norat T; Slimani N; Riboli E
    Int J Cancer; 2006 Feb; 118(3):728-38. PubMed ID: 16094628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
    Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
    BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of body mass index on surgical outcomes of robotic partial nephrectomy.
    Isac WE; Autorino R; Hillyer SP; Hernandez AV; Stein RJ; Kaouk JH
    BJU Int; 2012 Dec; 110(11 Pt C):E997-E1002. PubMed ID: 23106799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.